EnglishFrançaisEspañol
Consultation: Implications of NPT research and development for people living with HIV

Consultation: Implications of NPT research and development for people living with HIV

Click read more to access all presentations from the Amsterdam Consultation - 5-6 July 2010

The state of HIV vaccine research (Andrea von Lieven, International AIDS Vaccine Initiative—IAVI)
How are HIV-positive people involved in vaccines research? (Anuar Luna, RedLa+)
The state of ARV-based microbicides research (Thomas Mertenskoetter, International Partnership for Microbicides)
Treatment-as-prevention models: What are the opportunities and challenges around treatment as prevention? (Edwin Bernard)
The state of PrEP research and preparedness (Cindra Feuer, AVAC)
PrEP hype and hope: What should make HIV-positive people worry or rejoice? What shouldn’t? (Ebony Johnson, ICW)
The role of normative agencies: What are the lessons learned from the engagement of HIV-positive people? (Chris Mallouris, GNP+)
Community engagement and advocacy, particularly in Africa (Samu Dube, Global Campaign for Microbicides—GCM)
The experience of HIV-positive women in Africa engaged in NPT efforts (Lucy Wambura, NEPHAK)
The case for rectal microbicides: challenges and opportunities for advocacy (Marc-André LeBlanc, International Rectal Microbicide Advocates—IRMA)
The landscape of sexual health for HIV-positive gay men (Jack Arayawongchai, APN+)
back to top

GNP+, van Diemenstraat 194, 1013 CP, Amsterdam, The Netherlands, T: +31-20-423 4114, F:+31-20-423 4224, E: infognp@gnpplus.net